Patents Assigned to DUSA Pharmaceuticals Inc.
  • Patent number: 9339540
    Abstract: This application is directed to a method of treating onychomycosis by applying a phototherapeutic agent to a nail structure, waiting for a period of at least three days, and exposing the nail to light that causes an activation reaction. The phototherapeutic agent may be amino levulinic acid, alkylated derivatives of ALA, and their pharmaceutically acceptable salts.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: May 17, 2016
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventor: Scott Lundahl
  • Patent number: 9241957
    Abstract: The present invention provides compositions and methods for decreasing photosensitivity induced by photodynamic therapy (PDT). The compositions and methods of the present method employ porphyrin complexing molecules as agents for reducing photosensitivity.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: January 26, 2016
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventors: Scott Lundahl, Stuart Marcus
  • Publication number: 20150105667
    Abstract: An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity. A light sensor monitors output from the U-shaped tubes to provide a signal for adjusting the output from the tubes.
    Type: Application
    Filed: May 20, 2014
    Publication date: April 16, 2015
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott LUNDAHL, Rebecca Kozodoy, Ronald Carroll, Elton Leppelmeier
  • Publication number: 20140316491
    Abstract: The present invention provides compositions and methods for decreasing photosensitivity induced by photodynamic therapy (PDT). The compositions and methods of the present method employ porphyrin complexing molecules as agents for reducing photosensitivity.
    Type: Application
    Filed: November 25, 2013
    Publication date: October 23, 2014
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Stuart Marcus
  • Patent number: 8758418
    Abstract: An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity. A light sensor monitors output from the U-shaped tubes to provide a signal for adjusting the output from the tubes.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: June 24, 2014
    Assignee: Dusa Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Rebecca Kozodoy, Ronald Carroll, Elton Leppelmeier
  • Publication number: 20140074075
    Abstract: The invention encompasses a method of inhibiting the growth of hair in skin including epilation of follicles in the skin, waiting until within 5 days of the commencement of metanagen, applying a photodynamic agent to the skin, and exposing the skin to photoactivating light.
    Type: Application
    Filed: August 28, 2013
    Publication date: March 13, 2014
    Applicant: DUSA PHARMACEUTICALS, INC.
    Inventor: SCOTT LUNDAHL
  • Publication number: 20140052049
    Abstract: This application is directed to a method of treating onychomycosis by applying a phototherapeutic agent to a nail structure, waiting for a period of at least three days, and exposing the nail to light that causes an activation reaction. The phototherapeutic agent may be amino levulinic acid, alkylated derivatives of ALA, and their pharmaceutically acceptable salts.
    Type: Application
    Filed: August 13, 2013
    Publication date: February 20, 2014
    Applicant: DUSA PHARMACEUTICALS, INC.
    Inventor: SCOTT LUNDAHL
  • Publication number: 20140046289
    Abstract: This application is directed to a method of treating a patient with acne by applying a photodynamic agent to skin having acne lesions, waiting at least 12 hours, and then exposing the skin to which the photodynamic agent has been applied to light that causes an activation reaction.
    Type: Application
    Filed: August 9, 2013
    Publication date: February 13, 2014
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventor: Scott Lundahl
  • Patent number: 8609073
    Abstract: The present invention provides compositions and methods for decreasing photosensitivity induced by photodynamic therapy (PDT). The compositions and methods of the present method employ porphyrin complexing molecules as agents for reducing photosensitivity.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: December 17, 2013
    Assignee: Dusa Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Stuart Marcus
  • Patent number: 8216289
    Abstract: An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. Adjustment of the ballast voltage controls the output power of the tubes. The tubes are supported by a sheet-metal or plastic housing and are covered by a polycarbonate shield which directs cooling airflow within the unit and prevents glass-patient contact in the vent of tube breakage. An aluminum reflector located behind the tubes increases both the output irradiance and the uniformity of the output distribution. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: July 10, 2012
    Assignee: Dusa Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Rebecca Kozodoy, Ronald Carroll, Elton Leppelmeier
  • Patent number: 8030836
    Abstract: An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. Adjustment of the ballast voltage controls the output power of the tubes. The tubes are supported by a sheet-metal or plastic housing and are covered by a polycarbonate shield which directs cooling airflow within the unit and prevents glass-patient contact in the vent of tube breakage. An aluminum reflector located behind the tubes increases both the output irradiance and the uniformity of the output distribution. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity.
    Type: Grant
    Filed: November 19, 2009
    Date of Patent: October 4, 2011
    Assignee: Dusa Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Rebecca Kozodoy, Ronald Carroll, Elton Leppelmeier
  • Patent number: 8015653
    Abstract: An applicator device for applying a substance to an area of the body that is difficult to reach includes a collapsible handle and a head portion rotatably mounted on one end. The head portion includes an attachment means, which can comprise either a field of hooks or a field of loops. The attachment means receives a two-sided pad engagement member that preferably has fields of loops or hooks on one side to engage the respective hooks or loops of the attachment member, and a field of hooks on its opposite side. The hooks of the pad engagement member can securely retain a pad that carries the substance to be applied to the body.
    Type: Grant
    Filed: January 12, 2006
    Date of Patent: September 13, 2011
    Assignee: Dusa Pharmaceuticals, Inc.
    Inventors: Michael Bargiel, Joshua J. Nelson, Glenn Walters, Frank Pollard
  • Patent number: 7723910
    Abstract: A method of photodynamically diagnosing or treating a contoured surface includes topically applying 5-aminolevulinic acid to the contoured surface and irradiating the contoured surface with substantially uniform intensity visible light from a plurality of light sources generally conforming to the contoured surface. The plurality of light sources may comprise fluorescent tubes.
    Type: Grant
    Filed: March 9, 2007
    Date of Patent: May 25, 2010
    Assignee: DUSA Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Rebecca Kozodoy, Ronald Carroll, Elton Leppelmeier
  • Patent number: 7190109
    Abstract: An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. Adjustment of the ballast voltage controls the output power of the tubes. The tubes are supported by a sheet-metal or plastic housing and are covered by a polycarbonate shield which directs cooling airflow within the unit and prevents glass-patient contact in the event of tube breakage. An aluminum reflector located behind the tubes increases both the output irradiance and the uniformity of the output distribution. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity.
    Type: Grant
    Filed: January 13, 2004
    Date of Patent: March 13, 2007
    Assignee: Dusa Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Rebecca Kozodoy, Ronald Carroll, Elton Leppelmeier
  • Patent number: 6958035
    Abstract: A medical device sheath apparatus including: a fitting being suitable for receiving the medical device in a self sealing manner; a first sheath for receiving the medical device as it passes through the fitting; a second sheath surrounding the first sheath; a dilator defining a treatment area, coupled to at least the second sheath, and being suitable for dilating a bodily cavity and passing therapeutic or diagnostic energy in such forms as electromagnetic radiation or acoustic energy there through; and, a window operatively positioned with respect to the first sheath so as to enable viewing of an area substantially adjacent the second sheath upon insertion of the medical device into the apparatus.
    Type: Grant
    Filed: December 30, 2002
    Date of Patent: October 25, 2005
    Assignee: Dusa Pharmaceuticals, Inc
    Inventors: Marc David Friedman, Shawn Timothy Moynihan, Anthony Mark Smith
  • Publication number: 20040157905
    Abstract: Methods of detecting and treating rapidly growing exogenous cells, such as Protista, or parasites, that preferentially accumulate a photoactivatable porphyrin in which 5-aminolevulinic acid or precursor thereof is administered to the patient, or contacted to the exogenous cells, in an amount sufficient to induce synthesis fluorescence and/or photosensitizing concentrations of a protoporphyrin IX in the exogenous cells, followed by exposure of the exogenous cells to light of photoactivating wavelengths.
    Type: Application
    Filed: September 17, 2003
    Publication date: August 12, 2004
    Applicants: DUSA PHARMACEUTICALS, INC., Queen's University at Kingston
    Inventors: James C. Kennedy, Roy H. Pottier, Robert L. Reid
  • Publication number: 20040143308
    Abstract: An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. Adjustment of the ballast voltage controls the output power of the tubes. The tubes are supported by a sheet-metal or plastic housing and are covered by a polycarbonate shield which directs cooling airflow within the unit and prevents glass-patient contact in the event of tube breakage. An aluminum reflector located behind the tubes increases both the output irradiance and the uniformity of the output distribution. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity.
    Type: Application
    Filed: January 13, 2004
    Publication date: July 22, 2004
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Rebecca Kozodoy, Ronald Carroll, Elton Leppelmeier
  • Patent number: 6709446
    Abstract: An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. Adjustment of the ballast voltage controls the output power of the tubes. The tubes are supported by a sheet-metal or plastic housing and are covered by a polycarbonate shield which directs cooling airflow within the unit and prevents glass-patient contact in the event of tube breakage. An aluminum reflector located behind the tubes increases both the output irradiance and the uniformity of the output distribution. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity.
    Type: Grant
    Filed: January 31, 2001
    Date of Patent: March 23, 2004
    Assignee: Dusa Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Rebecca Kozodoy, Ronald Carroll, Elton Leppelmeier
  • Patent number: D552792
    Type: Grant
    Filed: January 12, 2006
    Date of Patent: October 9, 2007
    Assignee: DUSA Pharmaceuticals, Inc.
    Inventors: Michael Bargiel, Joshua J. Nelson, Glenn Walters, Frank Pollard
  • Patent number: D613872
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: April 13, 2010
    Assignee: DUSA Pharmaceuticals, Inc.
    Inventors: Mark Carota, Teresa Nelson, Andrea Nicolaisen